National Health Funding for Low Dose Naltrexone in Australia
- Trevor George Stephens
- Closed on
- Cancer sufferers MS sufferers and HIV+ persons
Thank you to those who signed my petition and thank you also for taking the time to respond to those who emailed me. However, the response was poor to say the least overall while I have changed my mind about the actual efficacy of LDN in my own case.
I was diagnosed as being HIV+ in 1987: I participated in the Ozone trial in the Philippines in 1993 while practicing various alternative and natural therapies and am 60 years of age in Sept. 2009 and am healthy and well.
I pursued further Ozone treatment in 1999 in Kenya with the scientist who developed that particular method of delivery called Polyatomic Apheresis - The late Basil Wainwright - and returned to Australia early 2000. I discovered in that year a seeming decrease in my CD4 cells and a concomitant decrease in my platelets, so I went on medication then and remained fairly steadily on it for some time - four years -with a couple of intermittent breaks from it due to the development of small lumps in my sides (abdominal area) -a side effect. In all of this time my cd4's have been only between 200 and 300: however, after being on LDN for some three months - from about September 2008 - they showed the most significant increase I have seen since the Ozone trial in 1993.....CD4's were 350 and CD8's were 1096 with a non detectable viral load.
I had a few weeks off around the Christmas and have now passed another three/four month period taking 4.5 mg every night. My latest results at May 2009 are ... non detectable viral load and CD4 count of 293. The present cost of this medication at the lower end of the scale is $100+.00 every three months. I am presently in receipt of a disability support pension. I have an interest in drawing official attention to this medication and having it listed on the pharmaceutical benefits listings.
Please send this on to anyone with serious immune boosting concerns / view the LDN site and sign the petition. Return this petition to me on the 20th January 2012 for review.
Click 'Tell' to send this petition on and you will assist in maintaining its momentum and growth or email me for the link.
We petition the Australian government to make funds available for trials and research for LDN to achieve a licence and public availability. This medication must be added to the pharmaceuticals benefits listings.
We petition the Australian government to make funding available, either directly through taxes or indirectly by directing research bodies to provide funding, to undergo trials for the generic drug, Low Dose Naltrexone (LDN).
Primarily this is to be done for Cancer since there lies the biggest savings of life and economy, but then also for the many other diseases, such as MS, Crohns disease, Fibromyalgia, Rheumatoid Arthritis, HIV/Aids and many more.
Alternatively, the drug should be made available on the basis of it's widespread use and the widespread positive reports of the many doctors around the world who are currently using it. The evidence about this drug has overtaken the trials process already and as such, we ask also that this drug be made available as front line treatment, now. The research should then be performed to confirm the drug and resolve the many unanswered questions surrounding it.
To sumarise, we ask for the funding to be provided and the drug to be made freely available to those who request it. The drug has been proven safe at high dose usage so the safety trials are done, and we know of no drugs which become unsafe at low dose when safe at high ones. In 25 years, the drug industry has ignored this drug due to lack of return on investment, so we believe that only government led intervention can break this scandalous apathy. LDN now, save our sick, save our economy.
Please fund LDN Now!
The National Health Funding for Low Dose Naltrexone in Australia petition to Cancer sufferers MS sufferers and HIV+ persons was written by Trevor George Stephens and is in the category Health at GoPetition.